EnGene Therapeutics Inc. Earnings At $32.50 Mln In Q3

India, Sept. 8 -- enGene Therapeutics Inc. (ENGN) released a profit for third quarter of $32.50 million

The company's earnings totaled $32.50 million, or $0.47 per share. This compares with $28.99 million, or $0.57 per share, last year.

enGene Therapeutics Inc. earnings at a glance (GAAP) :

-Earnings: $32.50 Mln. vs. $28.99 Mln. last year.-EPS: $0.47 vs. $0.57 last year.

For comments and feedback contact: [e-mail]

Published by HT Digital Content Services with permission from RTT News....